Anhui Huangshan Capsule Inkomsten in het verleden
Verleden criteriumcontroles 2/6
Anhui Huangshan Capsule has been growing earnings at an average annual rate of 9.7%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 9.2% per year. Anhui Huangshan Capsule's return on equity is 5.6%, and it has net margins of 11.1%.
Belangrijke informatie
9.7%
Groei van de winst
9.7%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 12.1% |
| Inkomstengroei | 9.2% |
| Rendement op eigen vermogen | 5.6% |
| Nettomarge | 11.1% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Anhui Huangshan Capsule Co., Ltd. (SZSE:002817) Investors Are Less Pessimistic Than Expected
Sep 30
Anhui Huangshan Capsule's (SZSE:002817) Shareholders Have More To Worry About Than Only Soft Earnings
Aug 28Returns On Capital Are Showing Encouraging Signs At Anhui Huangshan Capsule (SZSE:002817)
Jun 06Anhui Huangshan Capsule Co., Ltd.'s (SZSE:002817) 26% Price Boost Is Out Of Tune With Earnings
Mar 08Opbrengsten en kosten
Hoe Anhui Huangshan Capsule geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 454 | 50 | 59 | 15 |
| 30 Jun 24 | 442 | 57 | 55 | 14 |
| 31 Mar 24 | 438 | 60 | 59 | 15 |
| 31 Dec 23 | 463 | 65 | 62 | 16 |
| 30 Sep 23 | 483 | 68 | 62 | 15 |
| 30 Jun 23 | 476 | 67 | 64 | 16 |
| 31 Mar 23 | 470 | 67 | 57 | 16 |
| 01 Jan 23 | 428 | 61 | 55 | 15 |
| 30 Sep 22 | 403 | 62 | 54 | 13 |
| 30 Jun 22 | 392 | 62 | 55 | 14 |
| 31 Mar 22 | 377 | 60 | 57 | 14 |
| 31 Dec 21 | 380 | 57 | 59 | 13 |
| 30 Sep 21 | 382 | 54 | 52 | 14 |
| 30 Jun 21 | 372 | 53 | 55 | 12 |
| 31 Mar 21 | 353 | 47 | 57 | 10 |
| 31 Dec 20 | 319 | 45 | 57 | 9 |
| 30 Sep 20 | 304 | 41 | 74 | 10 |
| 30 Jun 20 | 312 | 40 | 74 | 11 |
| 31 Mar 20 | 318 | 39 | 76 | 12 |
| 31 Dec 19 | 326 | 39 | 74 | 13 |
| 30 Sep 19 | 320 | 39 | 64 | 16 |
| 30 Jun 19 | 305 | 34 | 59 | 18 |
| 31 Mar 19 | 297 | 34 | 57 | 15 |
| 31 Dec 18 | 295 | 36 | 57 | 13 |
| 30 Sep 18 | 286 | 37 | 56 | 8 |
| 30 Jun 18 | 284 | 40 | 51 | 12 |
| 31 Mar 18 | 285 | 44 | 49 | 12 |
| 31 Dec 17 | 286 | 46 | 51 | 10 |
| 30 Sep 17 | 289 | 47 | 56 | 9 |
| 30 Jun 17 | 290 | 47 | 64 | 0 |
| 31 Mar 17 | 290 | 50 | 63 | 0 |
| 31 Dec 16 | 283 | 52 | 60 | 0 |
| 31 Dec 15 | 254 | 55 | 49 | 0 |
| 31 Dec 14 | 273 | 52 | 50 | 0 |
| 31 Dec 13 | 269 | 48 | 51 | 0 |
Kwaliteitswinsten: 002817 has high quality earnings.
Groeiende winstmarge: 002817's current net profit margins (11.1%) are lower than last year (14.1%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 002817's earnings have grown by 9.7% per year over the past 5 years.
Versnelling van de groei: 002817's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: 002817 had negative earnings growth (-25.9%) over the past year, making it difficult to compare to the Chemicals industry average (-3.8%).
Rendement op eigen vermogen
Hoge ROE: 002817's Return on Equity (5.6%) is considered low.